Company / Operating Income
Beta Bionics, Inc. Operating Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$71.7M
FY2025
5-year range
-$71.7M / -$35.9M
FY2023-FY2025
Trend
-58.4%
vs FY2024
Sector context
#125 of 156
Health Care
What the data says
Beta Bionics, Inc.'s operating income of -$72M is lower than 80% of companies in the Health Care sector (FY2025). Declined from -$36M to -$72M over the past 2 years.
Based on SEC 10-K filings.
-$72M in FY2025.
Declined from -$36M to -$72M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 156This company -$71.7M Sector average $733.1M
▼
-109.8% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 58.4% year-over-year.
- Ranks #125 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$71.7M | -58.4% |
| FY2024 | -$45.3M | -26.2% |
| FY2023 | -$35.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026